Last update :
16/06/2024
Antibiotic   Ceftriaxone disodium  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Acantex Argentina, Chile
Amcef Mexico
Antibacin Greece
Aurofox
Axobat Italy
Azatyl Greece
Baktisef Turkey
Biotrakson Poland
Bixon Italy
Bresec Greece
Cefaday Turkey
Cefonova Sweden
Cefotrix Austria, Denmark, Germany
Cefrag Italy
Cephaxon Turkey
Davixon Italy
Daytrix Italy
Deixim Italy
Desefin Turkey
Eftry Italy
Eqicept Turkey
Farcef Greece
Fidato Italy
Forsef Turkey
Frineg Italy
Gladius Greece
Glorixone Greece
Kappacef Italy
Labilex Greece
Lendacin Croatia, Poland, Russian, Slovenia
Lidacef Croatia
Mesporin Portugal, Saudi Arabia
Nevakson Turkey
Nilson Italy
Novocef Turkey
Oframax Texte introuvable (616, ), Poland
Olisef Slovenia
Panatrix Italy
Pantoxon Italy
Ragex Italy
Rocefalin Spain
Rocefin Brazil, Italy
Rocephalin Denmark, Finland, Norway, Sweden
Rocephin Canada, Germany, Greece, Netherlands, Poland, Portugal, Republic of South Africa, Switzerland, Thailand, Turkey, United States of America
Rocephine Belgium, France, Germany
Sirtap Italy
Tartriakson Poland
Tercefon Austria
Travilan Greece
Unacefin Turkey
Valexime Italy
Stability of mixtures   Injection   Stability of mixtures : Ceftriaxone disodium     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass Sodium chloride 0,9% 20 mg/ml
Injection   Ceftriaxone disodium   
Injection   Clindamycin phosphate 12 mg/ml
25°C
8 Hour
Light 432
Level of evidence D
Glass Glucose 5% 20 mg/ml
Injection   Ceftriaxone disodium   
Injection   Clindamycin phosphate 12 mg/ml
25°C
1 Hour
Light 432
Level of evidence D
Polyvinyl chloride NaCl 0,9% or Glucose 5% 10 mg/ml
Injection   Ceftriaxone disodium   
Injection   Metronidazole 7,5 mg/ml
24-26°C
24 Hour
Not specified 11
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 10 mg/ml
Injection   Ceftriaxone disodium   
Injection   Metronidazole 7,5 mg/ml
4-6°C
72 Hour
Protect from light 11
Level of evidence A
Polyvinyl chloride None 10 mg/ml
Injection   Ceftriaxone disodium   
Injection   Metronidazole 5 mg/ml
25°C
3 Day
Not specified 649
Level of evidence B
Polyvinyl chloride None 10 mg/ml
Injection   Ceftriaxone disodium   
Injection   Metronidazole 5 mg/ml
8°C
72 Hour
Not specified 282
Level of evidence A
Polypropylene Water for Injection 450 mg/ml
Injection   Ceftriaxone disodium   
Injection   Lidocaine hydrochloride 10 mg/ml
-15°C
56 Day
Protect from light 279
Level of evidence B+
Polypropylene Water for Injection 450 mg/ml
Injection   Ceftriaxone disodium   
Injection   Lidocaine hydrochloride 10 mg/ml
20°C
24 Hour
Protect from light 279
Level of evidence B+
Polypropylene Water for Injection 450 mg/ml
Injection   Ceftriaxone disodium   
Injection   Lidocaine hydrochloride 10 mg/ml
4°C
10 Day
Protect from light 279
Level of evidence B+
Polypropylen Syringe Water for Injection 40 mg/ml
Injection   Ceftriaxone disodium   
Injection   Paracetamol 10 mg/ml
25°C
4 Hour
Not specified 3571
Level of evidence A+
Not specified Sodium chloride 0,9% 16,7 mg/ml
Injection   Ceftriaxone disodium   
Injection   Daptomycin 16,7 mg/ml
22°C-28°C
2 Hour
Not specified 1937
Level of evidence C+

  Mentions Légales